Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Anjali Advani, MD

216.444.6833

Anjali Advani, MD

Appointed: 2002

Anjali Advani, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.445.9354
WorkFax:216.444.9464
Anjali Advani, MD
Department: Translational Hematology and Oncology Research
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.445.9354
WorkFax:216.444.9464
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Anjali S. Advani, MD, is a Staff Physician in the Department of Hematologic Oncology and Blood Disorders and Director of the Inpatient Leukemia Program, Taussig Cancer Institute. She is also Associate Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. 

She completed her medical degree, internal medicine residency and hematology/oncology fellowship at Duke University Medical Center. She has been at the Cleveland Clinic since 2002. 

Dr. Advani's major clinical interests include myelodysplasia and acute leukemias, with a particular emphasis on molecular targeted therapies and novel treatment strategies for acute myeloid leukemia and acute lymphocytic leukemia. 

She is a member of the Southwest Oncology Group Leukemia Committee and serves as Co-Chair for the Data Safety and Monitoring Board committee for clinical trials at the Case Comprehensive Cancer Center.

Professional Highlights

  • Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
  • Co-Chair, Data and Safety Monitoring Board, Case Comprehensive Cancer Center
  • Director, Inpatient Leukemia Unit
  • Principal Investigator, Southwest Oncology Group

Education & Fellowships

Fellowship - Duke University Medical Center
Hematology/Oncology
Durham, NC USA
2002
Residency - Duke University Medical Center
Internal Medicine
Durham, NC USA
1999
Medical School - Duke University School of Medicine
Durham, NC USA
1996
Undergraduate - Princeton University
Princeton, NJ USA
1992

Certifications

  • Internal Medicine

Specialty Interests

Leukemia, myelodysplasia, Acute Lymphocytic Leukemia (ALL), acute myeloid leukemia, aplastic anemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, Leukopenia Myelodysplastic Syndrome (MDS), myeloproliferative disorders, cancer

Awards & Honors

Teacher of the Year Award, Hematology/Oncology, 2006-2007
Teacher of the Year Award, Hematology/ Oncology 2007-2008
Cleveland Best Doctors, 2011
Nominee, Leukemia/ Lymphoma Society Woman of the Year 2011

Memberships

  • Southwest Oncology Group Leukemia Committee
  • American Society of Hematology
  • American Society of Clinical Oncology

Treatment & Services

  • Blood Tests
  • Blood Transfusion
  • Chemotherapy
  • Clinical Trials
  • Medical Oncology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/28/2014, Dr. Advani has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English